Our CFO, Inna Zhuranskaya, attended the Latham & Watkins European Healthcare & Life Sciences Investor Symposium in London. It was a valuable opportunity to engage with key industry leaders and investors. The initial dialogues with Johan Hueffer, Senior Partner, Principal Investments at Novo Holdings; Peter Hames, Vice President, Corporate Development at Pharmanovia; and Arun Krishnan, Vice President, Corporate Development – Biopharma & Consumer Healthcare at Norgine, were particularly insightful. We look forward to continuing these meaningful conversations as we explore new avenues for collaboration and growth.